Table 3.
Cancer Age-adjusted Incidence Based-mortality (IBM) by Site and Sex — US-Affiliated Pacific Islands, 2008–2013a,b
| American Samoa | Guam | Commonwealth of the Northern Mariana Islands | Federated States of Micronesia | Marshall Islands | Palau | Hawai‘i Asian/Pacific Islanderc | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rank | Rate | Rank | Rate | Rank | Rate | Rank | Rate | Rank | Rate | Rank | Rate | Rank | Rate | |
| Males | ||||||||||||||
| Total | 21.7 (11.9–35.6) | 133.2 (119.2–148.3) | 22.7 (9.7–42.4) | 28.9 (20.4–39.7) | 142.0 (101.5–191) | 151.5 (108.7–203.4) | 136.9 (132.7–141.2) | |||||||
| Colon & rectum | 4 | 2.4 (0.5–7.8) | 3 | 12.3 (8.2–17.5) | 0d | 4 | 3.6 (0.6–10.1) | 5 | 2.7 (0.5–11.9) | 6 | 11.4 (1.7–32.7) | 2 | 15.8 (14.4–17.3) | |
| Esophagus | 0d | 8 | 3.4 (1.4–6.5) | 0d | 0d | 0d | 8 | 5.8 (1.1–17.9) | 9 | 3.7 (3–4.4) | ||||
| Leukemia | 7 | 0.7 (0.1–5.0) | 9 | 1.7 (0.5–3.9) | 3 | 2.1 (0.1–10.0) | 6 | 1.0 (0.1–4.1) | 8 | 1.0 (0–10.1) | 7 | 6.1 (1.2–18.4) | 8 | 4.9 (4.1–5.7) |
| Liver | 5 | 2.0 (0.2–7.6) | 2 | 20.7 (15.9–26.5) | 1 | 5.7 (0.3–20.8) | 2 | 5.1 (2–10.4) | 2 | 24.5 (8.5–50.8) | 2 | 28.0 (13–51.1) | 4 | 9.9 (8.8–11.1) |
| Lung & bronchus | 1 | 4.4 (1.1–11.4) | 1 | 50.0 (41.3–59.6) | 2 | 4.8 (1.7–11.8) | 1 | 6.0 (2.8–11.4) | 1 | 35.0 (17.1–61.5) | 1 | 35.6 (17.9–61.7) | 1 | 37.3 (35.2–39.6) |
| Oral cavity & pharynx | 0d | 6 | 4.6 (2.5–7.5) | 0d | 3 | 5.0 (2–10.2) | 4 | 9.3 (4.4–19.8) | 4 | 16.8 (4.6–39.4) | 7 | 4.3 (3.6–5.1) | ||
| Pancreas | 6 | 1.2 (0–6.4) | 5 | 5.6 (3.1–9.2) | 5 | 0.7 (0–6.4) | 8 | 0.5 (0–3.4) | 6 | 1.5 (0.2–10.5) | 0d | 3 | 11 (9.8–12.2) | |
| Prostate | 3 | 3.7 (0.1–14.8) | 4 | 8.5 (5.2–13.0) | 0d | 6 | 1.0 (0.1–4.2) | 3 | 9.4 (1.6–26.8) | 3 | 26.9 (8.8–57.3) | 5 | 9.7 (8.6–10.8) | |
| Stomach | 2 | 4.1 (0.7–11.6) | 7 | 4.5 (2.2–7.9) | 4 | 1.0 (0.1–6.5) | 5 | 1.4 (0.3–4.6) | 7 | 1.1 (0–10.3) | 5 | 11.6 (2.1–31.7) | 6 | 7.8 (6.8–8.8) |
| Thyroid | 0d | 10 | 1.2 (0.1–3.7) | 0d | 0d | 0d | 9 | 2.6 (0.1–13.7) | 10 | 0.6 (0.3–0.9) | ||||
| Females | ||||||||||||||
| Total | 42.8 (28.1–61.4) | 72.2 (62.7–82.7) | 19.0 (7.4–37.5) | 23.2 (15.7–32.7) | 120.3 (87.2–160.2) | 107.7 (77.5–145.0) | 88.6 (85.6–91.7) | |||||||
| Breast | 1 | 11.2 (5.3–20.3) | 2 | 7.6 (4.8–11.3) | 4 | 0.6 (0–6.0) | 1 | 4.1 (1.6–8.6) | 3 | 12.9 (5.9–24.9) | 7 | 5.8 (0.6–19.3) | 2 | 10.8 (9.7–11.9) |
| Cervix | 5 | 4.2 (0.6–12.6) | 9 | 1.9 (0.8–3.7) | 0d | 3 | 3.2 (1.3–6.8) | 1 | 34.0 (18.4–56) | 3 | 11.7 (4.7–24.8) | 10 | 1.7 (1.2–2.2) | |
| Colon & Rectum | 0d | 3 | 5.2 (2.9–8.5) | 0d | 6 | 1.9 (0.2–6.1) | 0d | 9 | 4.7 (0.5–16.6) | 3 | 9.8 (8.9–10.9) | |||
| Esophagus | 0d | 13 | 0.3 (0–1.5) | 0d | 0d | 0d | 10 | 3.1 (0.1–14.6) | 13 | 0.3 (0.2–0.6) | ||||
| Leukemia | 7 | 0.3 (0–4.0) | 9 | 1.9 (0.7–4.0) | 0d | 7 | 0.5 (0–2.8) | 10 | 3.9 (1.3–11.7) | 12 | 2.0 (0.1–11.3) | 8 | 3.1 (2.6–3.8) | |
| Liver | 0d | 5 | 3.9 (1.9–6.8) | 0d | 5 | 2.2 (0.3–6.6) | 4 | 6.9 (2–17.6) | 2 | 15.2 (5.6–31.9) | 8 | 3.1 (2.6–3.7) | ||
| Lung & bronchus | 0d | 1 | 22.5 (17.2–28.7) | 0d | 3 | 3.2 (0.8–8.1) | 2 | 23 (7.7–48.2) | 1 | 19.4 (7.8–38.6) | 1 | 19.8 (18.4–21.3) | ||
| Oral cavity & pharynx | 6 | 2.7 (0.1–10.9) | 9 | 1.9 (0.6–4.2) | 3 | 3.2 (0.5–10.7) | 7 | 0.5 (0–2.9) | 7 | 5.0 (0.2–19.2) | 8 | 5.2 (1.0–15.8) | 11 | 1.2 (0.9–1.6) |
| Ovary | 4 | 4.7 (0.8–13.0) | 8 | 2.7 (1.2–5.2) | 0d | 7 | 0.5 (0–2.8) | 7 | 5.0 (1.7–13.4) | 5 | 7.3 (1.3–21.2) | 6 | 3.7 (3.1–4.4) | |
| Pancreas | 0d | 7 | 3.2 (1.5–5.8) | 0d | 7 | 0.5 (0–2.9) | 5 | 6.8 (0.4–24.1) | 6 | 6.3 (0.7–20.4) | 4 | 8.1 (7.3–9.1) | ||
| Stomach | 3 | 4.9 (1.2–12.4) | 4 | 4.0 (1.9–7.1) | 1 | 8.9 (1.1–26.0) | 7 | 0.5 (0–2.9) | 6 | 5.6 (0.4–19.8) | 12 | 2.0 (0.1–11.3) | 7 | 3.4 (2.9–4.1) |
| Thyroid | 8 | 0.9 (0–5.3) | 12 | 1.0 (0.2–2.8) | 0d | 0d | 9 | 4.5 (0.1–18.8) | 10 | 3.1 (0.1–14.6) | 12 | 0.7 (0.5–1) | ||
| Uterus | 2 | 8.8 (2.9–19.0) | 6 | 3.4 (1.7–5.8) | 2 | 4.8 (0.7–14.5) | 2 | 3.6 (0.9–8.8) | 11 | 3.5 (0.7–12.1) | 4 | 8.9 (1.7–24.4) | 5 | 4.8 (4.1–5.5) |
Data from Pacific Regional Central Cancer Registry Cancer Council of the Pacific Islands, based on vital status deceased was reported with a cause-specific death classification attributable to cancer diagnosis, year of death January 1, 2008–December 30, 2013. IBM rates are per 100,000 persons and age-adjusted to 2000 US Standard population.
Based on chart review using available clinical information from clinical notes, death summaries, pathology notes, and imaging results in cancer registry, cases were coded with cause of death using the International Statistical Classification of Diseases and Related Health Problems, 10th Revision (ICD-10) 2016 version. World Health Organization. International Classification of Diseases for Oncology, Third Edition, First Revision. [Internet]. Geneva: World Health Organization, 2013 [cited 2018 April 2]. Available from: http://codes.iarc.fr/.
Surveillance, Epidemiology, and End Results (SEER) registry data (2000–2015), with a cause-specific death classification attributable to cancer diagnosis, among Asian or Pacific Islander, diagnosed in Hawai‘i 2008–2013.
Rate was not calculated as case count was zero.